Role of mTOR Inhibition in Kidney Cancer
0 Views
administrator
07/10/23
James J. Hsieh, MD, PhD; Thomas Hutson, DO, PharmD, FACP; and Martin H. Voss, MD, review the clinical rationale for mTOR inhibition in the treatment of renal cell carcinoma and its current role in the first and second line.
-
Category
Show more
Facebook Comments
No comments found